サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/15 | 5,787 | 5,833 | 5,716 | 5,771 | -36 | -0.6% | 143,400 |
| 2024/04/12 | 5,732 | 5,813 | 5,732 | 5,807 | +75 | +1.3% | 153,800 |
| 2024/04/11 | 5,690 | 5,764 | 5,642 | 5,732 | -6 | -0.1% | 127,400 |
| 2024/04/10 | 5,733 | 5,791 | 5,724 | 5,738 | -13 | -0.2% | 91,700 |
| 2024/04/09 | 5,761 | 5,792 | 5,689 | 5,751 | -54 | -0.9% | 130,600 |
| 2024/04/08 | 5,840 | 5,889 | 5,751 | 5,805 | +61 | +1.1% | 149,600 |
| 2024/04/05 | 5,680 | 5,744 | 5,639 | 5,744 | +64 | +1.1% | 134,000 |
| 2024/04/04 | 5,656 | 5,718 | 5,622 | 5,680 | +38 | +0.7% | 127,400 |
| 2024/04/03 | 5,621 | 5,726 | 5,600 | 5,642 | -2 | ±0% | 189,100 |
| 2024/04/02 | 5,797 | 5,797 | 5,579 | 5,644 | -192 | -3.3% | 507,500 |
| 2024/04/01 | 6,016 | 6,020 | 5,812 | 5,836 | -194 | -3.2% | 170,800 |
| 2024/03/29 | 5,819 | 6,040 | 5,780 | 6,030 | +118 | +2% | 154,900 |
| 2024/03/28 | 6,000 | 6,046 | 5,910 | 5,912 | -169 | -2.8% | 152,900 |
| 2024/03/27 | 5,991 | 6,113 | 5,926 | 6,081 | +109 | +1.8% | 351,600 |
| 2024/03/26 | 5,979 | 5,994 | 5,902 | 5,972 | -66 | -1.1% | 295,200 |
| 2024/03/25 | 6,148 | 6,154 | 6,005 | 6,038 | -136 | -2.2% | 304,600 |
| 2024/03/22 | 6,320 | 6,338 | 6,048 | 6,174 | -144 | -2.3% | 327,000 |
| 2024/03/21 | 6,390 | 6,411 | 6,271 | 6,318 | -11 | -0.2% | 258,000 |
| 2024/03/19 | 6,294 | 6,374 | 6,260 | 6,329 | +14 | +0.2% | 146,700 |
| 2024/03/18 | 6,393 | 6,425 | 6,216 | 6,315 | -13 | -0.2% | 208,800 |
| 2024/03/15 | 6,450 | 6,450 | 6,298 | 6,328 | -66 | -1% | 285,300 |
| 2024/03/14 | 6,339 | 6,432 | 6,284 | 6,394 | +146 | +2.3% | 354,000 |
| 2024/03/13 | 6,262 | 6,340 | 6,180 | 6,248 | +53 | +0.9% | 203,300 |
| 2024/03/12 | 6,227 | 6,228 | 6,073 | 6,195 | -22 | -0.4% | 188,200 |
| 2024/03/11 | 6,210 | 6,344 | 6,117 | 6,217 | +88 | +1.4% | 214,900 |
| 2024/03/08 | 6,111 | 6,189 | 6,064 | 6,129 | -82 | -1.3% | 149,000 |
| 2024/03/07 | 6,247 | 6,379 | 6,190 | 6,211 | +25 | +0.4% | 179,400 |
| 2024/03/06 | 6,298 | 6,498 | 6,093 | 6,186 | -73 | -1.2% | 425,600 |
| 2024/03/05 | 5,860 | 6,330 | 5,825 | 6,259 | +399 | +6.8% | 497,300 |
| 2024/03/04 | 5,896 | 5,945 | 5,824 | 5,860 | +7 | +0.1% | 193,500 |
| 2024/03/01 | 5,769 | 5,881 | 5,758 | 5,853 | +109 | +1.9% | 220,500 |
| 2024/02/29 | 5,751 | 5,782 | 5,692 | 5,744 | -10 | -0.2% | 320,200 |
| 2024/02/28 | 5,760 | 5,809 | 5,738 | 5,754 | -6 | -0.1% | 174,000 |
| 2024/02/27 | 5,819 | 5,823 | 5,714 | 5,760 | -60 | -1% | 312,600 |
| 2024/02/26 | 5,995 | 6,046 | 5,793 | 5,820 | -75 | -1.3% | 260,100 |
| 2024/02/22 | 5,984 | 6,004 | 5,880 | 5,895 | -19 | -0.3% | 162,400 |
| 2024/02/21 | 5,956 | 5,966 | 5,865 | 5,914 | -92 | -1.5% | 302,500 |
| 2024/02/20 | 5,962 | 6,146 | 5,920 | 6,006 | +106 | +1.8% | 445,700 |
| 2024/02/19 | 5,752 | 5,915 | 5,716 | 5,900 | +190 | +3.3% | 223,800 |
| 2024/02/16 | 5,945 | 5,945 | 5,647 | 5,710 | -74 | -1.3% | 417,800 |
| 2024/02/15 | 6,120 | 6,127 | 5,764 | 5,784 | -350 | -5.7% | 415,300 |
| 2024/02/14 | 5,871 | 6,345 | 5,773 | 6,134 | +257 | +4.4% | 887,100 |
| 2024/02/13 | 5,817 | 5,912 | 5,774 | 5,877 | +131 | +2.3% | 304,500 |
| 2024/02/09 | 5,680 | 5,746 | 5,673 | 5,746 | +10 | +0.2% | 197,800 |
| 2024/02/08 | 5,695 | 5,790 | 5,662 | 5,736 | +41 | +0.7% | 156,400 |
| 2024/02/07 | 5,700 | 5,775 | 5,678 | 5,695 | -15 | -0.3% | 224,900 |
| 2024/02/06 | 5,700 | 5,775 | 5,690 | 5,710 | +30 | +0.5% | 230,500 |
| 2024/02/05 | 5,761 | 5,768 | 5,680 | 5,680 | -68 | -1.2% | 220,800 |
| 2024/02/02 | 5,799 | 5,832 | 5,725 | 5,748 | +104 | +1.8% | 245,300 |
| 2024/02/01 | 5,599 | 5,698 | 5,599 | 5,644 | +45 | +0.8% | 198,600 |
301～
350
件表示中 / 1044件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 180,500円 | +5.9% | +684.6% | 3.05% | 11.98倍 | 1.20倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ツムラ | 351,300円 | +3.8% | -19.9% | 3.87% | 11.41倍 | 0.87倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 309,000円 | +8.0% | -15.3% | 4.01% | 8.67倍 | 0.84倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 152,900円 | +5.0% | +1.5% | 0.00% | 13.08倍 | 3.48倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 398,500円 | +3.6% | +6.1% | 3.01% | 13.42倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
